Age at diagnosis of Type 2 diabetes in Germany: a nationwide analysis based on claims data from 69 million people

被引:19
|
作者
Jacobs, E. [1 ,2 ]
Rathmann, W. [1 ,2 ]
Toennies, T. [1 ]
Arendt, D. [3 ]
Marchowez, M. [3 ]
Veith, L. [3 ]
Kuss, O. [1 ,2 ,4 ,5 ]
Brinks, R. [1 ,6 ]
Hoyer, A. [1 ]
机构
[1] Heinrich Heine Univ, German Diabet Ctr, Inst Biometr & Epidemiol, Leibniz Ctr Diabet Res, Dusseldorf, Germany
[2] German Ctr Diabet Res, Munich, Germany
[3] Ludwig Maximilians Univ Munchen, Dept Stat, Munich, Germany
[4] Heinrich Heine Univ Dusseldorf, Dusseldorf Univ Hosp, Inst Med Stat, Dusseldorf, Germany
[5] Heinrich Heine Univ Dusseldorf, Med Fac, Dusseldorf, Germany
[6] Heinrich Heine Univ Dusseldorf, Hiller Res Unit Rheumatol, Dusseldorf, Germany
关键词
D O I
10.1111/dme.14100
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim For many European countries, including Germany, no valid estimates are available on age at diagnosis of Type 2 diabetes. Thus, we aimed to estimate the age at diagnosis in Germany. Methods Age at diagnosis of Type 2 diabetes in Germany was estimated based on Type 2 diabetes prevalence and incidence and the age distribution of the German population. Age- and sex-specific incidence and prevalence in 2014/2015, based on claims data from statutory health insurance (n= 69 000 000, similar to 85% of the German population), and the age pyramid for Germany in 2015 were used for the calculation. Age at Type 2 diabetes diagnosis was stratified by sex. CIs were estimated using bootstrap methods. In addition, the age range in which 50% of the population received a diagnosis of Type 2 diabetes was calculated (the interquartile range). Results The mean +/- sd age at Type 2 diabetes diagnosis in 2015 was 61.0 +/- 13.4 years (95% CI 60.9-61.0) in men. Women were diagnosed similar to 2 years later than men (mean age 63.4 +/- 14.9 years; 95% CI 63.4-63.5). The age range in which 50% of the population was diagnosed with diabetes was 53-72 years for men and 54-76 years for women. Conclusions The sex differences are mainly attributable to a higher incidence of Type 2 diabetes in men than women during middle age and the higher absolute number of women in the older ages. The early age at diabetes diagnosis compared to average life expectancy means that the risk of diabetes-related complications is increased.
引用
收藏
页码:1723 / 1727
页数:5
相关论文
共 50 条
  • [21] Age at type 2 diabetes diagnosis among adults in Germany in 2014, 2019 and 2020
    Rathmann, Wolfgang
    Seidel-Jacobs, Esther
    Hering, Ramona
    Schulz, Mandy
    Hoyer, Annika
    Toennies, Thaddaeus
    [J]. ACTA DIABETOLOGICA, 2023, 60 (11) : 1591 - 1593
  • [22] Prevalence and incidence of documented diabetes based on health claims data-reference analysis for diabetes surveillance in Germany
    Schmidt, Christian
    Reitzle, Lukas
    Dress, Jochen
    Rommel, Alexander
    Ziese, Thomas
    Heidemann, Christin
    [J]. BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2020, 63 (01) : 93 - 102
  • [23] Prescribing valproate to girls and women of childbearing age in Germany: Analysis of trends based on claims data
    Wentzell, Nadine
    Haug, Ulrike
    Schink, Tania
    Engel, Susanne
    Liebentraut, Judith
    Linder, Roland
    Onken, Marlies
    Schaefer, Christof
    Dathe, Katarina
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 320 - 320
  • [24] Association between age at diagnosis of type 2 diabetes and cardiovascular and mortality risks: a nationwide population-based study
    Seo, D.
    Kim, M.
    Cho, Y.
    Ahn, S.
    Hong, S.
    Kim, S.
    [J]. DIABETOLOGIA, 2022, 65 (SUPPL 1) : S429 - S429
  • [25] CHARACTERISTICS OF PEOPLE WITH TYPE 2 DIABETES MELLITUS INITIATING AN INSULIN PUMP: DATA FROM A LARGE COMMERCIAL CLAIMS DATABASE
    Hankosky, E.
    Katz, M.
    Fan, L.
    Meeks, A.
    Chinthammit, C.
    Eby, E.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A148 - A148
  • [26] Association Between Age at Diagnosis of Type 2 Diabetes and Cardiovascular Diseases: A Nationwide, Population-Based, Cohort Study
    Hu, Chunyan
    Lin, Lin
    Zhu, Yujing
    Zhang, Yi
    Wang, Shuangyuan
    Zhang, Jie
    Qi, Hongyan
    Li, Mian
    Zhu, Yuanyue
    Huo, Yanan
    Wan, Qin
    Qin, Yingfen
    Hu, Ruying
    Shi, Lixin
    Su, Qing
    Yu, Xuefeng
    Yan, Li
    Qin, Guijun
    Tang, Xulei
    Chen, Gang
    Xu, Min
    Xu, Yu
    Wang, Tiange
    Zhao, Zhiyun
    Gao, Zhengnan
    Wang, Guixia
    Shen, Feixia
    Luo, Zuojie
    Chen, Li
    Li, Qiang
    Ye, Zhen
    Zhang, Yinfei
    Liu, Chao
    Wang, Youmin
    Yang, Tao
    Deng, Huacong
    Chen, Lulu
    Zeng, Tianshu
    Li, Donghui
    Zhao, Jiajun
    Mu, Yiming
    Bi, Yufang
    Wang, Weiqing
    Ning, Guang
    Wu, Shengli
    Chen, Yuhong
    Lu, Jieli
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [27] Prevalence of obesity and cardiovascular disease in adults with type 2 diabetes and use of diabetes medication in Germany: A claims data study
    Hennies, Nora
    Goergens, Sven W.
    Killer, Jonas
    Otto, Thorsten
    Richter, Lena M.
    Mueller-Wieland, Dirk
    Haeckl, Dennis
    [J]. DIABETES OBESITY & METABOLISM, 2024,
  • [28] Population-Level Prediction of Type 2 Diabetes From Claims Data and Analysis of Risk Factors
    Razavian, Narges
    Blecker, Saul
    Schmidt, Ann Marie
    Smith-McLallen, Aaron
    Nigam, Somesh
    Sontag, David
    [J]. BIG DATA, 2015, 3 (04) : 277 - 287
  • [29] Disease progression of heart failure in type 2 diabetes patients in Germany; a real world data analysis using health insurance claims data
    Lee, K.
    Wilke, M.
    Wagner, T.
    Kennedy, A.
    Koehler, F.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 866 - 866
  • [30] The burden of poor glycaemic control in people with newly diagnosed type 2 diabetes in Sweden: A health economic modelling analysis based on nationwide data
    Hellgren, Margareta
    Svensson, Ann-Marie
    Franzen, Stefan
    Ericsson, Asa
    Gudbjornsdottir, Soffia
    Ekstrom, Nils
    Bertilsson, Rebecka
    Valentine, William
    Malkin, Samuel
    [J]. DIABETES OBESITY & METABOLISM, 2021, 23 (07): : 1604 - 1613